Settembre 2011 - Volume XXX - numero 7
Pagine elettroniche
1Clinica Pediatrica, Università Milano-Bicocca, Azienda Ospedaliera
San Gerardo, Monza
2Divisione di Pediatria, Ospedale “Valduce”,
Como
3Divisione di Dermatologia, Azienda Ospedaliera
San Gerardo, Monza
4Dipartimento di Medicina Preventiva,
ASL Provincia Milano 2, Melegnano (Milano)
Indirizzo per corrispondenza: cghitti@alice.it
Key words: Acute haemorrhagic oedema of infancy, Measles, mumps and rubella vaccination, Leukocytoclastic vasculitis
The Authors report a case of acute haemorrhagic oedema of infancy (AHEI) in a 15-month-old male child, which occurred 9 days after measles, mumps and rubella vaccination and improved in one month without therapy, reaching a complete clinical resolution. No recurrence of the disease was observed during the following 24 months.
Vuoi citare questo contributo?
Pagine elettroniche
SC di Pediatria, Ospedale SS. Annunziata, ASL Taranto
Indirizzo per corrispondenza: pediatriataranto@hotmail.it
Key words: Stevens-Johnson syndrome, Toxic epidermal necrolysis, Mycoplasma pneumoniae infection
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are 2 rare (1-2 cases per million population per year) but life-threatening mucocutaneous reactions characterized by detachment of epidermis, acute skin blisters, and mucous membrane erosions. Both SJS and TEN represent a spectrum of a single disease process. Several drugs are highly suspected to cause SJS/TEN. Non-medication factors have also been reported to increase the risk of SJS/TEN: many viruses or bacteria can be trigger agents; many authors have documented that the majority of cases are related to Mycoplasma pneumoniae (MP). The article reports the case of a boy hospitalized for SJS/TEN-overlap triggered by MP pneumonia, which supports the evidence by other Authors that both SJS and TEN can be considered infection driven disorders. Documented cases of recurring SJS/TEN during re-infection with MP have not been found in current literature. So, this option should be included when treating children with MP infection.
Vuoi citare questo contributo?